Freedom to Heal Act of 2025

Doctors could give experimental Schedule I drugs

This bill would let licensed physicians apply to the U.S. Attorney General to register to give certain experimental Schedule I drugs to eligible Right to Try patients. Applications would be submitted electronically and would need proof of a valid Schedules II–V controlled substance registration, sponsor documentation that the drug is an eligible investigational drug and will be supplied with administration guidance, the quantity to be supplied, evidence state law allows the treatment, the physician's training and credentials, and a description of the storage and administration site. The Attorney General would have 45 days after a complete application to register the physician or issue an order to show cause. Doctors could only possess the drug amounts listed in their application or an approved supplemental notice (supplementals are deemed approved 30 days after filing unless an order to show cause is issued). One registration could cover related sites in the same city or county under the same institution if each site is reported before treatment. The Attorney General would have to issue an interim final rule within 240 days after enactment and a final rule no later than two years after that interim rule.